Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II StudyGlenn J. Hanna, Jochen H. Lorch, Krystof Misiwkeiwicz et al.|Clinical Cancer Research|2018Cited by 125